Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

News Conference News SCCT 2025

AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry

Yael L. Maxwell

July 21, 2025

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Conference News ACC 2020

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Yael L. Maxwell

March 28, 2020

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

Presentation CHIP Seattle 2019

CHIP 2.0:Where We Need to Go Next

Presenter: Ajay J. Kirtane

August 03, 2019

News Daily News

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Michael O'Riordan

August 16, 2018

Presentation CHIP Seattle 2017

Instent Restenosis

Presenter: Creighton W. Don

August 11, 2017

Presentation CHIP Seattle 2017

CABG vs PCI vs Mechanical Support

Presenter: Jason W. Smith

August 11, 2017

Presentation CHIP Seattle 2017

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

Presenter: Ajay J. Kirtane

August 10, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Daily News

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Michael O'Riordan

August 16, 2016

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

CHIP 2.0:Where We Need to Go Next

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Instent Restenosis

CABG vs PCI vs Mechanical Support

Yes, the Data Favor Invasive Management and Revascularization for These Patients (with Ischemic CM)

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content